These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 9743917)

  • 21. Insulin encapsulation in reinforced alginate microspheres prepared by internal gelation.
    Silva CM; Ribeiro AJ; Ferreira D; Veiga F
    Eur J Pharm Sci; 2006 Oct; 29(2):148-59. PubMed ID: 16952452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of sodium alginate as drug release modifier in matrix tablets.
    Liew CV; Chan LW; Ching AL; Heng PW
    Int J Pharm; 2006 Feb; 309(1-2):25-37. PubMed ID: 16364576
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alginate microspheres prepared by internal gelation: development and effect on insulin stability.
    Silva CM; Ribeiro AJ; Figueiredo IV; Gonçalves AR; Veiga F
    Int J Pharm; 2006 Mar; 311(1-2):1-10. PubMed ID: 16442757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Formulation and evaluation of gastroretentive floating drug delivery system of dipyridamole.
    Jiang H; Tian R; Hu W; Jia Y; Yuan P; Wang J; Zhang L
    Drug Dev Ind Pharm; 2015 Apr; 41(4):674-80. PubMed ID: 24588740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fabrication of flocculation-resistant pH/ionic strength/temperature multiresponsive hollow microspheres and their controlled release.
    Mu B; Liu P; Li X; Du P; Dong Y; Wang Y
    Mol Pharm; 2012 Jan; 9(1):91-101. PubMed ID: 22098247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of preparation conditions on the nutrient release properties of alginate-whey protein granular microspheres.
    Chen L; Subirade M
    Eur J Pharm Biopharm; 2007 Mar; 65(3):354-62. PubMed ID: 17150342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Description of the release of sodium ferulate from hydroxypropyl methylcellulose based matrix tablets in vitro].
    Li FQ; Hu JH
    Yao Xue Xue Bao; 2004 May; 39(5):389-91. PubMed ID: 15338886
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of processing parameters and formulation factors on the drug release from tablets powder-coated with Eudragit L 100-55.
    Sauer D; Zheng W; Coots LB; McGinity JW
    Eur J Pharm Biopharm; 2007 Sep; 67(2):464-75. PubMed ID: 17451929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of wet granulation on the erosion behaviour of an HPMC-lactose tablet, used as a rate-controlling component in a pulsatile drug delivery capsule formulation.
    McConville JT; Ross AC; Chambers AR; Smith G; Florence AJ; Stevens HN
    Eur J Pharm Biopharm; 2004 May; 57(3):541-9. PubMed ID: 15093604
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Release characteristics of diclofenac sodium from poly(vinyl alcohol)/sodium alginate and poly(vinyl alcohol)-grafted-poly(acrylamide)/sodium alginate blend beads.
    Sanli O; Ay N; Işiklan N
    Eur J Pharm Biopharm; 2007 Feb; 65(2):204-14. PubMed ID: 16996255
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mucoadhesive vaginal tablets as veterinary delivery system for the controlled release of an antimicrobial drug, acriflavine.
    Gavini E; Sanna V; Juliano C; Bonferoni MC; Giunchedi P
    AAPS PharmSciTech; 2002; 3(3):E20. PubMed ID: 12916935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
    Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alginate-whey protein granular microspheres as oral delivery vehicles for bioactive compounds.
    Chen L; Subirade M
    Biomaterials; 2006 Sep; 27(26):4646-54. PubMed ID: 16714058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Size control of calcium alginate beads containing living cells using micro-nozzle array.
    Sugiura S; Oda T; Izumida Y; Aoyagi Y; Satake M; Ochiai A; Ohkohchi N; Nakajima M
    Biomaterials; 2005 Jun; 26(16):3327-31. PubMed ID: 15603828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of Carbopol 71G-NF on the release of dextromethorphan hydrobromide from extended-release matrix tablets.
    Fayed MH; Mahrous GM; Ibrahim MA; Sakr A
    Pharm Dev Technol; 2013; 18(5):971-81. PubMed ID: 21639691
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets.
    Takka S; Rajbhandari S; Sakr A
    Eur J Pharm Biopharm; 2001 Jul; 52(1):75-82. PubMed ID: 11438426
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of formulation and process variables on in vitro release of theophylline from directly-compressed Eudragit matrix tablets.
    Ceballos A; Cirri M; Maestrelli F; Corti G; Mura P
    Farmaco; 2005; 60(11-12):913-8. PubMed ID: 16129436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of novel one-step dry-coated tablets as a platform for delayed-release tablets.
    Ozeki Y; Ando M; Watanabe Y; Danjo K
    J Control Release; 2004 Feb; 95(1):51-60. PubMed ID: 15013231
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro characterization and release study of Ambroxol hydrochloride matrix tablets prepared by direct compression.
    Abd-Elbary A; Haider M; Sayed S
    Pharm Dev Technol; 2012; 17(5):562-73. PubMed ID: 21428699
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum albumin-alginate coated microspheres: role of the inner gel in binding and release of the KRFK peptide.
    Callewaert M; Millot JM; Lesage J; Laurent-Maquin D; Edwards-Lévy F
    Int J Pharm; 2009 Jan; 366(1-2):103-10. PubMed ID: 18835344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.